September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Hagop Kantarjian: Historical development, current status, and future research of olverembatinib
Apr 18, 2025, 18:37

Hagop Kantarjian: Historical development, current status, and future research of olverembatinib

Hagop Kantarjian, Associate Vice President for Global Academic Programs at MD Anderson Cancer Center, shared on X a recent paper published in ACS Journals:

“Historical development, current status, and future research of olverembatinib, a new third-generation BCR::ABL1 TKI with significant activity and favorable safety profile.”

Olverembatinib in chronic myeloid leukemia—Review of historical development, current status, and future research

Authors: Hagop Kantarjian et al.

Hagop Kantarjian

See more posts by Hagop Kantarjian on OncoDaily.